Notably, similar to observations in the general population [26], we also confirmed the association between higher risk for SARS-CoV-2-positive result and several cofounders, including male gender, low SES, obesity, ADHD, low plasma vitamin D3 levels, and lack of previous influenza vaccination, independently of the possible protective effect of the somatotropin treatment. The gene discussed is GH1; the disease is attention deficit-hyperactivity disorder.